NCT05906264Completed
Pulmonary Rehabilitation Program in COPD Patient
Evaluation of Compliance and Effectiveness of Pulmonary Rehabilitation Program in COPD Patient
Source: ClinicalTrials.gov · Last updated 18 Mar 2025
Brief summary (registry, in English)
This study was designed in order to evaluate the compliance of a pulmonary rehabilitation program using a wearable device and the application effect of the program according to the characteristics of each patient, in COPD patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 64 (actual)
- First submitted
- 19 Apr 2022
- Start date
- 9 Jun 2022
- Primary completion date
- 14 Mar 2025
- Lead sponsor
- Samsung Medical Center
- Diseases
- COPD
- NCT number
- NCT05906264
What you commit to
- Study type: Interventional
- Participants enrolled: 64
- From 9 Jun 2022 to the primary completion date, 14 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with history of lung cancer surgery
- Patients with bronchiectasis, severe tuberculosis destroyed lung, active pulmonary tuberculosis, non-tuberculous mycobacterial lung disease (NTM), and idiopathic interstitial pneumonia
Who the study is looking for
- COPD patients 18 years of age or older
- ECOG PS (Eastern Cooperative Oncology Group Performance Status) \<2
- Smart phone user
- Those who understand the contents of the questionnaire and agree to the research
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samsung Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.